Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Sanofi’s chief executive officer (CEO), Paul Hudson said nothing would change as the company’s headquarters would remain in ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

(RTTNews) - Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest Territories, and the Yukon this fall. The administration ...

Sanofi (NASDAQ:SNY) shares gained on Friday after the French pharma giant exceeded analysts' estimates with its Q3 thanks mainly to earlier-than-anticipated vaccine sales and a 22% YoY rise in ...

Is modesty the new mode at Macquarie? It’s certainly the word that comes to mind when gazing upon the boardroom of Macquarie’s new global headquarters in Sydney. Not one piece of art hangs on ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...

(Reuters) - French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in the third quarter, boosted by an earlier-than-anticipated start of the vaccination season.

Sanofi revealed on Monday it had begun exclusive ... while maintaining both the company's headquarters and its research and development activities within France, reported The Guardian newspaper.

Sanofi reported a 25% boost in sales for its vaccines division during the third quarter, helped by earlier-than-anticipated orders of its flu shots as well as rising revenue from Beyfortus, its RSV ...